overnight semaglutide SkinnyRx: Injectable (GLP-1) Woman shares journey of weight

Wegovy (semaglutide 2.4 mg) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA and recommended by NICE (TA875, 2023) for managing overweight and obesity in adults

Address common side effects Supporting hydration, electrolyte balance, and overall well-being

My A1C numbers improved, my doc was pleased, and I just feel like a different person now at week 24

The objective is to help you maintain your results with as little medication as is reasonably possible, relying more on sustainable lifestyle strategies over time

some may find success at lower doses, while others require a gradual increase to reach their target weight